Back
Design Therapeutics Stock Price Chart
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.
Sell
27
DSGN
Design Therapeutics
Last Price:
$3.85
Seasonality Move:
6.31%
7 Day Trial
ALL ACCESS PASS
$
7
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.-
The current trend is moderately bearish and DSGN is experiencing slight buying pressure.
Design Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.96 | Sell |
| 20-day SMA: | 3.87 | Sell |
| 50-day SMA: | 3.74 | Buy |
| 200-day SMA: | 4.88 | Sell |
| 8-day EMA: | 3.92 | Sell |
| 20-day EMA: | 3.88 | Sell |
| 50-day EMA: | 3.49 | Buy |
| 200-day EMA: | 1.73 | Buy |
Design Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 48.75 | Sell |
| Chaikin Money Flow: | 19798 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.55 - 4.01) | Buy |
| Bollinger Bands (100): | (3.56 - 4.82) | Sell |
Design Therapeutics Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics Stock
Is Design Therapeutics Stock a Buy?
-
Design Therapeutics share price is 3.84 while DSGN 8-day simple moving average is 3.96, which is a Sell signal.
-
The stock price of DSGN is 3.84 while Design Therapeutics 20-day SMA is 3.87, which makes it a Sell.
-
Design Therapeutics 50-day simple moving average is 3.74 while DSGN share price is 3.84, making it a Buy technically.
-
DSGN stock price is 3.84 and Design Therapeutics 200-day simple moving average is 4.88, creating a Sell signal.
DSGN Technical Analysis vs Fundamental Analysis
Sell
27
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a SellThe current Design Therapeutics [DSGN] share price is $3.84. The Score for DSGN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Design Therapeutics Stock Info
Market Cap:
218M
Price in USD:
3.84
Share Volume:
66K
Design Therapeutics 52-Week Range
52-Week High:
7.77
52-Week Low:
2.60
Sell
27
Design Therapeutics (DSGN)
is a Sell
Design Therapeutics Share Price Forecast
-
What is the Design Therapeutics stock price today?The Design Therapeutics stock price is 3.84 USD today.
-
Will DSGN stock go up or go down?Design Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Design Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics is overvalued.
Is Design Therapeutics Stock a Buy?
-
Design Therapeutics share price is 3.84 while DSGN 8-day exponential moving average is 3.92, which is a Sell signal.
-
The stock price of DSGN is 3.84 while Design Therapeutics 20-day EMA is 3.88, which makes it a Sell.
-
Design Therapeutics 50-day exponential moving average is 3.49 while DSGN share price is 3.84, making it a Buy technically.
-
DSGN stock price is 3.84 and Design Therapeutics 200-day simple moving average is 1.73, creating a Buy signal.
Fundamental Analysis of Design Therapeutics
Is Design Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and an increase next year of $0.10 per share.
Technical Analysis of Design Therapeutics
Should I short Design Therapeutics stock?
-
DSGN Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Design Therapeutics is a Buy
-
Design Therapeutics Relative Strength Index (RSI) is 48.75, which suggest Design Therapeutics is oversold
-
The Bollinger Bands (25) for Design Therapeutics is (3.55 - 4.01), which suggest Design Therapeutics is a Sell
-
The Bollinger Bands (100) for Design Therapeutics is (3.56 - 4.82), which suggest Design Therapeutics is a Sell
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.